“…Antibodies reactive with the subunits of intermediate filaments have been extensively used over the last several years for tumor diagnosis, helping to distinguish between poorly differentiated neoplasms of mesenchymal, epithelial, myogenic, neuronal or astrocytic origins [II, 16,24,28,31,35,361. More recently, with the introduction of specific antibodies reactive with subsets of cytokeratin polypeptides, it became possible to distinguish between epithelial tumors of different cellular origins as well as between those displaying distinct degrees of differentiation [3,13,22,26,30,37,40,431. Of particular interest in those studies was the obser-* To whom offprint requests should be sent vation that as tumors develop, changes may occur in the pattern of cytokeratin polypeptides they express [25].…”